- Link Between Antidepressants And Suicidality In Teens? Carnegie Mellon
An interdisciplinary team of researchers from Carnegie Mellon University and The Ohio State University has received a five-year, $1.2 million grant from the National Institute of Mental Health to investigate the link between antidepressants and suicidality -- including suicidal thoughts, attempts and suicide deaths. - People With Depression Benefit More From Marriage Than Others
Depressed singles receive greater psychological benefits from getting married than those who are not depressed, new research shows. - Mylan Announces Tentative Approval For Venlafaxine Hydrochloride Tablets
Mylan Laboratories Inc. (NYSE: MYL) announced that the U.S. Food and Drug Administration has granted tentative approval for Mylan Pharmaceuticals Inc.'s Abbreviated New Drug Application for Venlafaxine Hydrochloride Tablets 25 mg (base), 37.5 mg (base), 50 mg (base), 75 mg (base) and 100 mg (base). - New Treatment Model For Bipolar Disorder Shows Promise
A new care model for bipolar disorder tested in veterans across the nation reduced their manic episodes and improved their quality of life, according to research led by a psychiatrist with the Providence Veterans Affairs Medical Center and Brown Medical School. - Violence At Work Significantly Boosts Clinical Depression Risk
Employees subjected to real or threatened violence at work run a major risk of becoming clinically depressed, indicates research in the Journal of Epidemiology and Community Health. - Medscape Clinical Review Supports Effectiveness And Safety Of New Non-Drug Blood Pressure Treatment
InterCure, Ltd., today announced the publication of a peer-reviewed clinical overview of seven clinical trials evaluating the efficacy of device-guided breathing. The study's authors conclude that RESPeRATE, an FDA-cleared over-the-counter therapeutic device, is an effective non-pharmacologic treatment option for treating hypertension with no side effects. - New Study: Despite Suicidality Risks, Patients On Antidepressants Have Received Far Less Follow-up
Despite concerns about suicidal thoughts and behavior for patients using antidepressants, a new study in the August issue of the peer-reviewed American Journal of Managed Care shows that few patients on these drugs received even the minimum level of follow-up care. - Experimental Medication Kicks Depression In Hours Instead Of Weeks
People with treatment-resistant depression experienced symptom relief in as little as two hours with a single intravenous dose of ketamine, a medication usually used in higher doses as an anesthetic in humans and animals, in a preliminary study. - Children And Teens Taking Antidepressants Might Be More Likely To Attempt, Complete Suicide
Antidepressant medications may be associated with suicide attempts and death in severely depressed children and adolescents but not in adults, according to an article in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. - Study Suggests Anesthetic Agent May Have Rapid Antidepressant Effects
A single intravenous infusion of a drug known as ketamine, which is a general anesthetic agent, may relieve symptoms of depression within two hours and remain effective for up to one week, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. - FDA Approves First Generic Venlafaxine
The Food and Drug Administration today approved the first generic version of Effexor (venlafaxine), an important step in the agency's effort to increase the availability of lower-cost generic medications. Venlafaxine is indicated for the treatment of major depressive disorder (MDD). - Alleviating The Burden Of Multiple Sclerosis
Depression, coordination and speech problems, muscle weakness and disability are just a few of the symptoms of Multiple Sclerosis (MS). Researchers from the Mouse Biology Unit of the European Molecular Biology Laboratory (EMBL) in Italy and the Department of Neuropathology at the Faculty of Medicine, University of Göttingen, Germany, have now discovered that these symptoms are aggravated by a specific signal in cells in the nervous system. - Angst And The Rail Commuter: Longer The Trip, Greater The Stress
Researchers know that the longer your drive to work, the more likely you are to feel frustrated and irritated and to experience physiological stress. - NicOx Completes Enrolment Ahead Of Schedule In ABPM Trial For Naproxcinod In Hypertensive Subjects
NicOx S.A. (Eurolist: NICOX) today announced that it has successfully completed subject enrolment in the ambulatory blood pressure monitoring (ABPM) trial for naproxcinod (HCT 3012). The randomization of 120 volunteer subjects with stable essential hypertension at 16 clinical centers in the United States was initiated in May this year and has been completed ahead of schedule. Results are anticipated in the fourth quarter of 2006. - Placebo Study Frames Depression Treatment Puzzle
Treating major depression can be quite a puzzle, and a newly published UCLA study suggests medication is just one of many potential pieces. - Higher Blood Pressure Associated With Decline In Walking Ability In Older Persons
Decline in lower limb function is common in older people, and worsening gait is associated with increased risk of dementia and death. However, factors contributing to gait difficulties in older persons are not well understood. A study by researchers at Rush University Medical Center suggests that higher blood pressure may be one factor associated with a decline in walking ability in later life. - FSU Professor Documents How Rising Gas Prices Affect Wallets, Psyches
The price of gas has doubled over the past three years, hovering around $3 a gallon nationally. Wayne Hochwarter, an associate professor of management in the College of Business at Florida State University in Tallahassee, Fla., recently conducted research to determine how increased gas prices have affected personal finance, as well as behavior at work. More than 300 employees across a wide range of occupations were surveyed. - Breastfed Babies Cope Better With Stress In Later Life Than Bottle Fed Babies
Breastfed babies cope better with stress in later life than bottle fed babies, suggests research published ahead of print in the Archives of Disease in Childhood - NicOx Completes Enrolment Ahead Of Schedule In ABPM Trial For Naproxcinod In Hypertensive Subject
NicOx S.A. (Eurolist: NICOX) today announced that it has successfully completed subject enrolment in the ambulatory blood pressure monitoring (ABPM) trial for naproxcinod (HCT 3012). The randomization of 120 volunteer subjects with stable essential hypertension at 16 clinical centers in the United States was initiated in May this year and has been completed ahead of schedule. Results are anticipated in the fourth quarter of 2006. - Greater Risk Of Accidents In Young Adult Drivers With ADHD
A pilot study conducted by researchers at the Washington Neuropsychological Institute found that a small group of young adults (n=14) with Attention-Deficit/Hyperactivity Disorder (ADHD) improved their driving safety performance when treated with once-daily Adderall XR(R), a leading ADHD medication. This study suggests the importance of effectively treating ADHD symptoms, as untreated ADHD compromises road safety by impairing an individual's ability to focus. - Penn State Researchers Say Education, Treatment Key To Averting Child Homicides
Mothers who suffer from serious bouts of postpartum depression and psychosis often don't get enough help before killing their children, but jailing them is not necessarily the answer, say two Penn State researchers who are publishing a new book: "Child Homicide: Parents Who Kill," with CRC Press, in August. - New Mothers Should Be Screened Regularly For Postpartum Depression
Physicians should screen mothers for postpartum depression regularly for at least a year following childbirth to better identify women who develop symptoms throughout the year and those whose depression persists, University of Rochester Medical Center researchers say.
|
